Recruiting NA INTERVENTIONAL 1-arm NCT05420233

The CROCO Study: CROhn's Disease COhort Study (CROCO)

Sponsor: AbbVie

Interventions MRE

Updated 6 times since 2022 Last updated: Dec 6, 2024 Started: Aug 1, 2021 Primary completion: Jul 31, 2030 Completion: Jul 31, 2030

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Crohn Disease, this trial is actively recruiting participants. The trial is conducted by AbbVie and has accumulated 6 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Recruiting NA
Jan 2025 — Sep 2025 [monthly]

Recruiting NA
Sep 2024 — Jan 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Oct 2023 — Jul 2024 [monthly]

Recruiting NA

▶ Show 1 earlier version

Jul 2022 — Oct 2023 [monthly]

Recruiting NA

First recorded

Aug 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

AbbVie
GLSMED Learning Health S.A.

Data source: GLSMED Learning Health S.A.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Almada, Portugal , Amiens, France , Barcelona, Spain , Clermont-Ferrand, France , Galdakao, Spain , Hull, United Kingdom , Hvidovre, Denmark , Lille, France , Lisbon, Portugal , Liège, Belgium and 10 more locations